CICCARELLI, Michele
 Distribuzione geografica
Continente #
AS - Asia 7.637
NA - Nord America 4.662
EU - Europa 1.935
SA - Sud America 337
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 14.604
Nazione #
HK - Hong Kong 6.135
US - Stati Uniti d'America 4.623
SG - Singapore 657
IT - Italia 596
RU - Federazione Russa 415
CN - Cina 406
BR - Brasile 308
DE - Germania 265
UA - Ucraina 199
VN - Vietnam 140
IE - Irlanda 135
FI - Finlandia 108
TR - Turchia 96
KR - Corea 80
SE - Svezia 51
IN - India 48
GB - Regno Unito 39
AT - Austria 38
NL - Olanda 20
CA - Canada 19
BD - Bangladesh 18
CZ - Repubblica Ceca 17
ES - Italia 16
PL - Polonia 14
MX - Messico 13
IQ - Iraq 11
FR - Francia 10
AR - Argentina 9
JP - Giappone 9
ZA - Sudafrica 8
EU - Europa 6
IL - Israele 6
CO - Colombia 5
PK - Pakistan 5
PY - Paraguay 5
UZ - Uzbekistan 5
IR - Iran 4
SA - Arabia Saudita 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DZ - Algeria 3
KE - Kenya 3
MA - Marocco 3
NI - Nicaragua 3
AL - Albania 2
CH - Svizzera 2
EC - Ecuador 2
HN - Honduras 2
ID - Indonesia 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
NG - Nigeria 2
RS - Serbia 2
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
KW - Kuwait 1
LY - Libia 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 14.604
Città #
Hong Kong 6.133
Ann Arbor 970
Wilmington 609
Chandler 488
Princeton 374
Jacksonville 269
Woodbridge 255
Singapore 248
Ashburn 206
Houston 162
Munich 129
Dublin 128
Moscow 109
Dearborn 98
Dong Ket 96
Naples 94
Beijing 91
Izmir 84
Salerno 78
Boardman 76
Andover 69
Nanjing 57
Turku 48
Pellezzano 44
Los Angeles 40
Nuremberg 40
Domicella 37
Dallas 36
Fisciano 36
Mestre 30
Fairfield 28
Nanchang 22
Pune 21
New York 20
Seattle 20
São Paulo 20
The Dalles 20
Guangzhou 19
San Francisco 19
Hebei 18
Shenyang 18
Changsha 17
Düsseldorf 17
Norwalk 17
Redwood City 17
Vienna 17
Washington 17
Columbus 16
Ho Chi Minh City 16
Council Bluffs 14
Rome 14
Sarno 14
Zelarino 14
Brno 13
Brooklyn 12
Jinan 12
Warsaw 12
Lappeenranta 11
London 11
Rio de Janeiro 11
Shenzhen 11
Amsterdam 10
Jiaxing 10
Santa Clara 10
Atlanta 9
Belo Horizonte 9
Falls Church 9
Hanoi 9
Milan 9
Tianjin 9
Tokyo 9
Phoenix 8
Shanghai 8
Cambridge 7
Helsinki 7
Mexico City 7
Stockholm 7
Würselen 7
Baghdad 6
Charlotte 6
Johannesburg 6
Napoli 6
San Diego 6
West Jordan 6
Ankara 5
Boston 5
Chennai 5
Chicago 5
Hanover 5
Lanzhou 5
Salvador 5
Tashkent 5
Turin 5
Varese 5
Venezia 5
Bengaluru 4
Buffalo 4
Contagem 4
Fuzhou 4
Joinville 4
Totale 11.897
Nome #
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 846
Remote Rehabilitation and Virtual Reality Interventions Using Motion Sensors for Chronic Low Back Pain: A Systematic Review of Biomechanical, Pain, Quality of Life, and Adherence Outcomes 811
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 514
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019 344
Potential Role of Global Longitudinal Strain in Cardiac and Oncological Patients Undergoing Cardio-Oncology Rehabilitation (CORE) 335
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 294
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 277
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 275
G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism. 275
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 274
Exercise training and cardiac rehabilitation in covid-19 patients with cardiovascular complications: State of art 253
The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study 236
Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients 222
Serum uric acid and left ventricular mass in essential hypertension 210
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 200
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 186
Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 185
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 184
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 183
AKT participates in endothelial dysfunction in hypertension. 148
Sirt1 activity in pbmcs as a biomarker of different heart failure phenotypes 145
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 140
Role of endothelial g protein-coupled receptor kinase 2 in angioedema 136
Cardiovascular Nursing in Rehabilitative Cardiology: A Review 128
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 128
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 126
Adrenergic receptors and metabolism: role in development of cardiovascular disease. 125
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 123
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 117
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy) 113
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 111
A novel vasoactive peptide “PG1” from buffalo ice-cream protects from angiotensin-evoked high blood pressure 111
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 109
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 108
Retrospective Study on Short-Term Reverse Cardiac Remodeling in Obese Patients Undergoing Sleeve Gastrectomy 106
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 106
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 104
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 103
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 100
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 100
AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve. 99
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 98
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 98
Metabolic Syndrome and Aging: Calcium Signaling as Common Regulator 97
Good at Heart: Preserving Cardiac Metabolism during aging 97
The favourable alliance between cardiomems and levosimendan in patients with advanced heart failure 96
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 96
GRK2 at the control shaft of cellular metabolism 95
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 94
Impaired neoangiogenesis in β₂-adrenoceptor gene-deficient mice: restoration by intravascular human β₂-adrenoceptor gene transfer and role of NFκB and CREB transcription factors. 94
CaMKII activity in the inflammatory response of cardiac diseases 92
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart 92
G Protein-Coupled Receptors: Structure, Signaling, and Physiology “Beta adrenergic receptors in cardiovascular and respiratory disease 91
Beta(2)-adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. 88
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 87
Rays Sting: The Acute Cellular Effects of Ionizing Radiation Exposure 87
An IoT-aware system for remote monitoring of patients with chronic heart failure 87
Messages from the Border: Novel Insights in Signal Transduction Pathways Involved in Tumor Invasion and Metastasis 85
In vivo properties of the proangiogenic peptide QK. 85
CaMKII protects MKP-1 from proteasome degradation in endothelial cells. 84
CHRONIC HEART FAILURE IN THE ELDERLY: STAGES IN THE EVOLUTION OF CHRONIC HEART FAILURE; THE ENDOTHELIAL BORDER; 83
Targeting the ASMase/S1P pathway protects from sortilin-evoked vascular damage in hypertension 82
Low Blood Pressure And Defective Vasoconstriction In Tie2-cre/grk2(fl/fl) mice 81
The Adrenergic System in Vascular Endothelial Cells 81
Antidiabetic and cardioprotective effects of pharmacological inhibition of GRK2 in db/db mice 81
Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy 81
Functional role of mitochondria in arrhythmogenesis 80
Endothelial alpha(1)-adrenoceptors regulate neo-angiogenesis. 79
Association Study Between Coronary Artery Disease and rs1333049 Polymorphism at 9p21.3 Locus in Italian Population 79
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 78
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. 77
Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease 77
Exploring the Role of Voice Assistants in Managing Noncommunicable Diseases: A Systematic Review on Clinical, Behavioral Outcomes, Quality of Life, and User Experiences 75
The possible role of chromosome X variability in hypertensive familiarity 75
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. 73
Ischemic neoangiogenesisenhanced by beta2-adrenergic receptor overexpression: a novel role for theendothelial adrenergic system. 72
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 71
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 68
Ischemic neoangiogenesis enhanced by beta 2-adrenergic receptor overexpression - A novel role for the endothelial adrenergic system. Circ Res, 97 (11): 1182-1189 NOV 25 2005. 66
Chapter 11 – Adrenergic Receptor 66
Changes in the Lipid Asset of HIV/HCV Patients after a Successful Course of Direct-Acting Antivirals 65
C2CD4B Evokes Oxidative Stress and Vascular Dysfunction via a PI3K/Akt/PKCα–Signaling Pathway 64
Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity 64
Cross-Talk between Neurohormonal Pathways and the Immune System in Heart Failure: A Review of the Literature 64
Growth inhibition of human hepatocellular carcinoma cells by overexpression of G protein-coupled receptor kinase 2 63
Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure 63
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 61
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 61
Dual role of GRK5 in cancer development and progression 61
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 61
The amino-terminal domain of GRK5 inhibits cardiac hypertrophy through the regulation of calcium-calmodulin dependent transcription factors 58
719 CIRCULATING SORTILIN LEVELS ARE INCREASED IN PATIENTS RECEIVING LONG-TERM WARFARIN AND ITS INHIBITION ATTENUATES WARFARIN-INDUCED VASCULAR CALCIFICATION 57
Autoantibodies against the cardiovascular protective BPIFB4 in hospitalized patients with COVID-19 56
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation 56
An explainable model for predicting Worsening Heart Failure based on genetic programming 51
Artificial intelligence as a business partner in cardiovascular precision medicine: An emerging approach for disease detection and treatment optimization 51
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients 50
Predictors of left ventricular reverse remodeling in patients with chronic heart failure 49
A novel promising frontier for human health: The beneficial effects of nutraceuticals in cardiovascular diseases 49
A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS 48
Totale 13.110
Categoria #
all - tutte 46.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021510 0 35 50 7 64 35 51 7 82 19 53 107
2021/2022653 5 0 3 10 20 14 52 27 78 67 82 295
2022/20231.157 112 111 89 128 129 218 3 112 177 5 55 18
2023/2024732 42 84 45 27 69 95 64 39 14 50 22 181
2024/20252.278 44 33 35 109 121 255 445 151 337 126 316 306
2025/20266.603 2.467 4.136 0 0 0 0 0 0 0 0 0 0
Totale 14.973